Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Psychiatry|February 8, 2011
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trialMichael H Allen, David Feifel, Michael D Lesem, et al.
Journal of Addiction Medicine|June 7, 2011
Effects of chronic, heavy cannabis use on executive functionsRebecca D Crean, Susan F Tapert, Arpi Minassian, et al.
General Hospital Psychiatry|November 7, 2009
The Psychiatric Emergency Research Collaboration-01: methods and resultsEdwin D Boudreaux, Michael H Allen, Cindy Claassen, et al.
Aging Brain|March 13, 2023
Chronic oxytocin administration in older men modulates functional connectivity during animacy perceptionPedro A Valdes-Hernandez, Rebecca Polk, Marilyn Horta, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 5, 2011
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapineMichael D Lesem, Tram K Tran-Johnson, Robert A Riesenberg, et al.
General Hospital Psychiatry|December 3, 2014
Individual risk factors for physician boundary violations: the role of attachment style, childhood trauma and maladaptive beliefsKai MacDonald, Andrés F Sciolla, David Folsom, et al.
General Hospital Psychiatry|November 11, 2015
Individual risk factors for physician boundary violations: the role of attachment style, childhood trauma and maladaptive beliefsKai MacDonald, Andrés F Sciolla, David Folsom, et al.
Psychopharmacology|July 13, 2011
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover studyGeorge Apostol, Walid Abi-Saab, Christopher J Kratochvil, et al.
Psychopharmacology|May 13, 2021
Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trialJillian M Rung, Marilyn Horta, Erin M Tammi, et al.
Focus (American Psychiatric Publishing)|June 24, 2022
Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled TrialLior Carmi, Aron Tendler, Alexander Bystritsky, et al.
Pageof 11